Clinical trial
To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement
NCT05116215 is registered in ClinicalTrials.gov with HoHo Biotech as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Evaluate the Safety of Treating Autoimmune Diseases With Molecular Hydrogen Supplement
- Lead sponsor
- HoHo Biotech
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- August 13, 2021
- Completion date
- August 12, 2022
- Enrollment
- 27 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.